Michael Matson
Stock Analyst at Needham
(2.62)
# 2,220
Out of 5,012 analysts
23
Total ratings
69.23%
Success rate
11.46%
Average return
Main Sectors:
Stocks Rated by Michael Matson
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
TFX Teleflex | Maintains: Buy | $408 → $423 | $126.89 | +233.36% | 4 | Jan 31, 2020 | |
INGN Inogen | Upgrades: Buy | $90 | $8.59 | +947.73% | 2 | Nov 6, 2019 | |
MMSI Merit Medical Systems | Initiates: Buy | $53 | $82.70 | -35.91% | 1 | Apr 20, 2018 | |
GMED Globus Medical | Upgrades: Buy | n/a | $59.31 | - | 1 | Apr 4, 2018 | |
RMD ResMed | Upgrades: Hold | n/a | $283.28 | - | 1 | Jan 23, 2018 | |
BSX Boston Scientific | Upgrades: Strong Buy | n/a | $95.90 | - | 1 | Dec 8, 2017 | |
LIVN LivaNova | Upgrades: Buy | n/a | $52.15 | - | 2 | Sep 15, 2017 | |
SYK Stryker | Upgrades: Hold | n/a | $369.24 | - | 4 | Aug 25, 2017 | |
MBLY Mobileye Global | Downgrades: Hold | n/a | $15.09 | - | 1 | Mar 14, 2017 | |
HOLX Hologic | Upgrades: Buy | n/a | $67.73 | - | 2 | Feb 15, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $83.82 | - | 1 | Aug 12, 2016 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.49 | - | 1 | Mar 3, 2016 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.75 | - | 1 | Feb 24, 2016 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $120.95 | - | 1 | Jan 29, 2016 |
Teleflex
Jan 31, 2020
Maintains: Buy
Price Target: $408 → $423
Current: $126.89
Upside: +233.36%
Inogen
Nov 6, 2019
Upgrades: Buy
Price Target: $90
Current: $8.59
Upside: +947.73%
Merit Medical Systems
Apr 20, 2018
Initiates: Buy
Price Target: $53
Current: $82.70
Upside: -35.91%
Globus Medical
Apr 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $59.31
Upside: -
ResMed
Jan 23, 2018
Upgrades: Hold
Price Target: n/a
Current: $283.28
Upside: -
Boston Scientific
Dec 8, 2017
Upgrades: Strong Buy
Price Target: n/a
Current: $95.90
Upside: -
LivaNova
Sep 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $52.15
Upside: -
Stryker
Aug 25, 2017
Upgrades: Hold
Price Target: n/a
Current: $369.24
Upside: -
Mobileye Global
Mar 14, 2017
Downgrades: Hold
Price Target: n/a
Current: $15.09
Upside: -
Hologic
Feb 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $67.73
Upside: -
Aug 12, 2016
Downgrades: Hold
Price Target: n/a
Current: $83.82
Upside: -
Mar 3, 2016
Downgrades: Neutral
Price Target: n/a
Current: $1.49
Upside: -
Feb 24, 2016
Downgrades: Hold
Price Target: n/a
Current: $2.75
Upside: -
Jan 29, 2016
Upgrades: Buy
Price Target: n/a
Current: $120.95
Upside: -